• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Bioorg Med Chem . Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease wi

tetano

Editor, Senior Moderator
Bioorg Med Chem


. 2024 Jan 5:103:117577.
doi: 10.1016/j.bmc.2023.117577. Online ahead of print. Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity

Daniel W Carney[SUP] 1 [/SUP], Abba E Leffler[SUP] 2 [/SUP], Jeffrey A Bell[SUP] 3 [/SUP], Asela S Chandrasinghe[SUP] 4 [/SUP], Cecilia Cheng[SUP] 5 [/SUP], Edcon Chang[SUP] 6 [/SUP], Adam Dornford[SUP] 7 [/SUP], Douglas R Dougan[SUP] 6 [/SUP], Leah L Frye[SUP] 4 [/SUP], Mary E Grimes[SUP] 4 [/SUP], Tim Knehans[SUP] 8 [/SUP], Jennifer L Knight[SUP] 3 [/SUP], Mallareddy Komandla[SUP] 6 [/SUP], Weston Lane[SUP] 9 [/SUP], Hubert Li[SUP] 5 [/SUP], Sophia R Newman[SUP] 4 [/SUP], Katalin Phimister[SUP] 10 [/SUP], Kumar S Saikatendu[SUP] 6 [/SUP], Hercules Silverstein[SUP] 4 [/SUP], Shaghayegh Vafaei[SUP] 3 [/SUP]



Affiliations
Free article Abstract

Small-molecule antivirals that prevent the replication of the SARS-CoV-2 virus by blocking the enzymatic activity of its main protease (Mpro) are and will be a tenet of pandemic preparedness. However, the peptidic nature of such compounds often precludes the design of compounds within favorable physical property ranges, limiting cellular activity. Here we describe the discovery of peptide aldehyde Mpro inhibitors with potent enzymatic and cellular antiviral activity. This structure-activity relationship (SAR) exploration was guided by the use of calculated hydration site thermodynamic maps (WaterMap) to drive potency via displacement of waters from high-energy sites. Thousands of diverse compounds were designed to target these high-energy hydration sites and then prioritized for synthesis by physics- and structure-based Free-Energy Perturbation (FEP+) simulations, which accurately predicted biochemical potencies. This approach ultimately led to the rapid discovery of lead compounds with unique SAR that exhibited potent enzymatic and cellular activity with excellent pan-coronavirus coverage.

Keywords: COVID-19; FEP+; Free-energy perturbation; Main protease; Mpro; Peptide aldehyde; Peptidomimetic; Protease inhibitor; SARS-CoV-2; WaterMap.

 
Back
Top Bottom